跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
泰得欣 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ceftazidime for Injection
Approved
化学药品
Ceftazidime for Injection
Hanmi Pharm. Co., Ltd.
🇨🇳 National Medical Products Administration
Approval Date
Dec 6, 2019
Approval ID
7MazXbVokxX
Company
Hanmi Pharm. Co., Ltd.
Type
化学药品
Approval Details
Approval Id
7MazXbVokxX
Approval Number
H20150610
Generic Name
注射用头孢他啶
Generic Name En
Ceftazidime for Injection
Trade Name
泰得欣
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.5g(按C22H22N6O7S2计)
Reg Date
2019-12-06
Expired Date
2024-12-05
Company Name
Hanmi Pharm. Co., Ltd.
Company Address
214, Muha-ro, Paltan-myeon, Hwaseong-si, Gyeonggi-do, Korea
Production Company Name
Hanmi Pharm. Co., Ltd.
Production Company Address
114, Chupalsandan-ro, Paengseong-eup, Pyeongtaek-si, Gyeonggi-do, Korea
Company Detail Path
/organization/hanmi-pharm-co-ltd
Production Company Detail Path
/organization/hanmi-pharm-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 6, 2019
Approval ID
7MazXbVokxX
Type
化学药品
Back to NMPA Approvals